Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ori Biotech
Manufacturing
Cellares, Ori dominate automated cell therapy production: report
The bulk of the field’s raised capital (81%) is held by Cellares and Ori Biotech, Tracxn said in a new report.
Fraiser Kansteiner
Jun 18, 2026 10:10am
FDA grants advanced manufacturing tag to Ori's IRO platform
Sep 3, 2025 4:00pm
Charles River looks to help bring Ori's CGT platform forward
Sep 18, 2024 8:01am
Kite will evaluate Cellares' cell therapy manufacturing platform
Jun 27, 2024 8:00am
Ori reveals automated cell therapy production platform
May 29, 2024 3:01pm
A series on advancements in cell & gene therapy manufacturing
May 10, 2024 8:54am
